5 Amino 1 MQ 5mg

5 Amino 1 MQ 5mg

5 Amino 1 MQ 5mg

$10.00

5 Amino 1 MQ 5mg (also known as 5-Amino-1-Methylquinolinium) is a research-grade peptide with potential applications in fat metabolism, weight loss, and cellular energy regulation. All our research peptides are tested for purity, ID, and labelled in the USA by Regenerative Health Peptides. It is provided exclusively for in-vitro research studies. This peptide is ideal for researchers investigating lipid metabolism, obesity, and adiposity regulation. Not for human or animal use.

Category:

Overview

5 Amino 1 MQ 5mg (5-Amino-1-Methylquinolinium) is a synthetic peptide that has shown potential in fat loss and energy metabolism research. It works by activating AMPK (AMP-activated protein kinase), a key regulator of fat oxidation and energy expenditure. 5 Amino 1 MQ enhances fat burning, improves mitochondrial function, and supports glucose metabolism, making it an important subject in obesity and weight management studies.

The peptide is of particular interest to researchers focused on lipid metabolism, insulin resistance, and cellular energy. It has also been linked to enhanced fat oxidation and weight loss in preclinical models.

Molecular Characteristics

Property Data
Sequence H-Glu-Asp-Gly-Tyr-Pro-Gln-Tyr-NH2
Molecular Weight 286.3 g/mol
CAS Number 102564-74-4
PubChem CID 6633814
Synonyms 5-Amino-1-Methylquinolinium, 5-Amino-1-Methyl-Quinolinium

 

Mechanisms of Action

5 Amino 1 MQ enhances fat metabolism by activating AMPK, which triggers fat oxidation and increases mitochondrial biogenesis. This leads to improved ATP production, increased lipid metabolism, and enhanced fat burning. Additionally, 5 Amino 1 MQ has been shown to improve insulin sensitivity and regulate glucose metabolism, making it relevant for studies on diabetes and metabolic syndrome.

Research Areas

  1. Fat Loss & Weight Management
    5 Amino 1 MQ has been shown to activate AMPK, which increases fat oxidation and enhances fat burning. Its impact on lipid metabolism and body composition makes it valuable for weight loss research and obesity studies.[1][2]
  2. Mitochondrial Function & Bioenergetics
    As a mitochondrial enhancer, 5 Amino 1 MQ supports ATP production and improves mitochondrial bioenergetics, making it crucial for cellular energy and metabolic health research.[3][4]
  3. Insulin Sensitivity & Glucose Metabolism
    5 Amino 1 MQ improves insulin sensitivity, making it relevant for diabetes and metabolic syndrome research. It modulates glucose metabolism, reduces insulin resistance, and improves lipid profiles.[5][6]
  4. Obesity & Adiposity Regulation
    Studies suggest that 5 Amino 1 MQ enhances lipid metabolism and helps reduce adiposity, making it a key peptide for obesity research and fat loss studies.[7][8]
  5. Metabolic Disease Research
    By influencing mitochondrial function and lipid oxidation, 5 Amino 1 MQ is a significant peptide for metabolic disease research, particularly diabetes and insulin resistance studies.[9][10]

Product Usage

5 Amino 1 MQ 5mg is provided for Research Use Only and is not intended for human or animal use. It is suitable exclusively for in-vitro studies (in glass) and has not been evaluated by the FDA for therapeutic purposes. Researchers must comply with all local regulations when handling and disposing of this peptide.

Disclaimer
All compounds and information provided by Regenerative Health Peptides are intended solely for research and educational purposes. These materials are not medicines, foods, or dietary supplements and must not be introduced into humans or animals. They are supplied exclusively for in-vitro laboratory studies; any other use is strictly prohibited by law. None of these products have been evaluated or approved by the FDA to diagnose, treat, cure, or prevent any disease.

2.1 Fat Loss & Weight Management

5 Amino 1 MQ has shown to activate AMPK, increasing fat oxidation and improving fat burning in preclinical studies. It has been tested in diet-induced obesity models where it helped reduce visceral fat and adiposity, making it valuable for weight loss and fat loss studies. By targeting the AMPK pathway, 5 Amino 1 MQ promotes lipid metabolism and energy expenditure, improving body composition.[11][12]

  • This peptide is significant for obesity and weight management research, especially for those targeting fat loss and improving metabolic health.

2.2 Mitochondrial Function & Bioenergetics

5 Amino 1 MQ plays a crucial role in enhancing mitochondrial bioenergetics, improving ATP production, and increasing fatty acid oxidation. This makes it an essential tool for research focused on cellular energy production and bioenergetics. Studies suggest that 5 Amino 1 MQ enhances the efficiency of mitochondria, contributing to improved metabolic function and fat burning.[13][14]

  • The peptide’s ability to increase mitochondrial efficiency has applications in aging, metabolic disease, and energy metabolism research.

2.3 Insulin Sensitivity & Glucose Metabolism

By improving insulin sensitivity, 5 Amino 1 MQ has shown potential in diabetes and metabolic syndrome research. It modulates glucose metabolism and fat storage, helping to regulate blood sugar levels. Research has shown that 5 Amino 1 MQ improves insulin action, making it useful in diabetic research and studies focused on glucose homeostasis and fat storage regulation in adipocytes and skeletal muscle cells.[15][16]

  • The peptide has been tested in preclinical diabetes models, where it improved insulin resistance and glucose uptake.

2.4 Obesity & Adiposity Regulation

In preclinical models, 5 Amino 1 MQ has been shown to reduce visceral fat and improve body composition by enhancing lipid oxidation and promoting fat metabolism. The peptide’s ability to increase fat burning and improve lipid profiles makes it an essential target in obesity and adiposity regulation research. 5 Amino 1 MQ can reduce adiposity and help control fat storage.[17][18]

  • 5 Amino 1 MQ is a key peptide for obesity research, focusing on fat loss, adiposity, and body composition improvement.

Reference List 

  1. Lee et al., Journal of Lipid Research 56, 392–406 (2015)
  2. Duan et al., Molecular Metabolism 5, 57–68 (2016)
  3. Li et al., Cell Reports 23, 347–359 (2018)
  4. Zhang et al., Diabetes 66, 2277–2289 (2017)
  5. Zhao et al., Journal of Clinical Investigation 128, 1192–1204 (2018)
  6. Sheng et al., Endocrine Reviews 39, 298–307 (2018)
  7. Wang et al., Journal of Endocrinology 224, 55–68 (2020)
  8. Li et al., Obesity 25, 242–254 (2017)
  9. Zhu et al., Endocrinology 160, 1592–1602 (2019)
  10. Bai et al., Scientific Reports 8, 15033 (2018)
  11. Wang et al., Molecular Metabolism 9, 84–97 (2018)
  12. Kang et al., Endocrinology 159, 498–510 (2018)
  13. Zhao et al., Diabetes 66, 2277–2289 (2017)
  14. Liu et al., Journal of Cellular Physiology 234, 3041–3051 (2019)
  15. Robinson et al., Molecular Metabolism 6, 71–83 (2017)
  16. Yang et al., Nature Communications 9, 4747 (2018)
  17. Zhou et al., American Journal of Physiology 305, 759–766 (2018)
  18. Sheng et al., Endocrine Reviews 39, 298–307 (2018)
  • Lyophilized / Dry powder: Store at -20 °C (dark, desiccated); shelf life ~12 months.
  • Dissolved (aqueous): sterile water, 4 °C, use within 7 days.
  • Long-term: aliquot & -80 °C for up to 6 months; avoid > 2 freeze-thaw cycles.